We also observed an independent association between HER2 expression and elevated levels of LDH, which is markedly upregulated in various cancers, including lymphoma, UC, renal cell carcinoma, and melanoma (Claps et al., 2022; Miholjcic et al., 2023). Here, ERBB2 is linked to renal cell carcinoma.